HCS Pharma
3D innovative hiPSC-based models including the microenvironment for phenotypic screening - Application on metabolic diseases
No infographics yet
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of a 3D in vitro pancreatic ductal adenocarcinoma model and the study of tumor-stroma interaction
Poster - Including the matricial tumoral microenvironment in 3D in vitro models by using a Hyaluronic-Acid-based hydroscaffold™
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including an innovative 3D modified hyaluronic acid hydroscaffold for phenotypic screening
Poster - A single procedure to generate functional hiPSCs-derived liver organoids -Towards an innovative tool suitable for drug screening
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physiological organs-on-chip (OoC)
Importance of matricial and cellular microenvironments in in vitro models for drug discovery in Parkinson’s disease
Simplifying 3d cell culture generation for high content screening with BIOMIMESYS® and the viaflo 96-384
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepatocytes functions for metabolism and toxicity studies
Abstract : a single procedure to generate functional hi ps cs-derived liver organoids - towards an innovative tools suitable for drug screening
Poster – Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotypic screening – Application on metabolic diseases - version DHU2020
No likes yet
Personal Information
Organization / Workplace
HCS PharmaLocation
Lille FranceIndustry
Medical / Health Care / Pharmaceuticals
Website
hcs-pharma.com/About
HCS Pharma is a biotechnology company focused on in vitro R&D, specializing in high content (HCA) and high throughput (HCS) cell imaging screening. HCS Pharma sells products based on BIOMIMESYS® technology, and develops its own 3D cellular models in its proprietary BIOMIMESYS® extracellular matrix. BIOMIMESYS® 3D culture technology faithfully reproduces the natural microenvironment of cells in 3D, to ensure more predictive results from in vitro studies, to reduce the time and cost of R&D, and animal testing in pharmaceutical, nutraceutical and cosmetic companies.